MPWT
VRTX icon

MassMutual Private Wealth & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Sell
28,385
-341
-1% -$151K 0.36% 63
2026
Q1 		$12.8M Buy
28,726
+812
+3% +$379K 0.35% 69
2025
Q4 		$12.7M Sell
27,914
-581
-2% -$250K 0.33% 75
2025
Q3 		$11.2M Buy
28,495
+1,704
+6% +$712K 0.28% 79
2025
Q2 		$11.9M Buy
26,791
+9,775
+57% +$4.5M 0.32% 75
2025
Q1 		$8.25M Buy
17,016
+10,774
+173% +$5.02M 0.24% 97
2024
Q4 		$2.51M Buy
6,242
+3,641
+140% +$1.69M 0.07% 183
2024
Q3 		$1.21M Buy
2,601
+1,607
+162% +$772K 0.03% 231
2024
Q2 		$466K Buy
994
+131
+15% +$56.9K 0.01% 307
2024
Q1 		$361K Buy
863
+175
+25% +$74K 0.01% 322
2023
Q4 		$280K Buy
688
+36
+6% +$13.3K 0.01% 341
2023
Q3 		$227K Buy
652
+61
+10% +$21.3K 0.01% 356
2023
Q2 		$208K Buy
591
+206
+54% +$69.4K 0.01% 356
2023
Q1 		$121K Buy
385
+126
+49% +$37.8K ﹤0.01% 399
2022
Q4 		$75K Buy
259
+4
+2% +$1.22K ﹤0.01% 444
2022
Q3 		$74K Sell
255
-21
-8% -$6.04K ﹤0.01% 426
2022
Q2 		$78K Buy
276
+20
+8% +$5.35K ﹤0.01% 409
2022
Q1 		$67K Sell
256
-38
-13% -$9.02K ﹤0.01% 433
2021
Q4 		$65K Sell
294
-151
-34% -$29.4K ﹤0.01% 458
2021
Q3 		$81K Buy
445
+27
+6% +$5.27K ﹤0.01% 422
2021
Q2 		$84K Sell
418
-30
-7% -$6.28K ﹤0.01% 417
2021
Q1 		$96K Sell
448
-483
-52% -$106K ﹤0.01% 386
2020
Q4 		$220K Sell
931
-384
-29% -$88.1K 0.01% 339
2020
Q3 		$358K Sell
1,315
-11,029
-89% -$3.04M 0.02% 290
2020
Q2 		$3.58M Sell
12,344
-2,004
-14% -$543K 0.23% 115
2020
Q1 		$3.41M Buy
14,348
+186
+1% +$42.7K 0.27% 91
2019
Q4 		$3.1M Sell
14,162
-206
-1% -$41.7K 0.19% 135
2019
Q3 		$2.43M Buy
14,368
+580
+4% +$103K 0.16% 147
2019
Q2 		$2.53M Buy
13,788
+1,272
+10% +$222K 0.17% 134
2019
Q1 		$2.3M Buy
12,516
+1,664
+15% +$307K 0.17% 140
2018
Q4 		$1.8M Buy
+10,852
New +$1.88M 0.15% 142
2018
Q3 		– Sell
-14
Closed -$2.38K – 1106
2018
Q2 		$2.38K Buy
+14
New +$2.17K ﹤0.01% 848
2018
Q1 		– Sell
-100
Closed -$15K – 1085
2017
Q4 		$15K Sell
100
-12
-11% -$1.78K ﹤0.01% 563
2017
Q3 		$17K Buy
112
+12
+12% +$1.81K ﹤0.01% 675
2017
Q2 		$12.9K Hold
100
– – ﹤0.01% 690
2017
Q1 		$10.9K Sell
100
-7
-7% -$616 ﹤0.01% 690
2016
Q4 		$7.88K Buy
+107
New +$8.71K ﹤0.01% 493
2016
Q2 		$11.4K Buy
132
+7
+6% +$605 ﹤0.01% 501
2016
Q1 		$9.94K Sell
125
-23
-16% -$2.08K ﹤0.01% 531
2015
Q4 		$18.6K Buy
+148
New +$17.9K ﹤0.01% 429

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MassMutual Private Wealth & Trust's VRTX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 1.2% in Q2 2026, selling an estimated $151K and leaving 28,385 shares worth $14.1M. The position accounts for 0.36% of the portfolio, ranked #63.

MassMutual Private Wealth & Trust first reported a position in VRTX in Q4 2015 and has held it in 40 quarters since. 733 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 28,385 shares of Vertex Pharmaceuticals worth $14.1M as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 341 Vertex Pharmaceuticals shares in Q2 2026, an estimated $151K.
  • Vertex Pharmaceuticals made up 0.36% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #63 holding.
  • MassMutual Private Wealth & Trust first reported a position in Vertex Pharmaceuticals in Q4 2015 and has held it in 40 quarters since.
  • 733 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.